We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$304M
AUM Growth
-$15.2M
Cap. Flow
-$23.2M
Cap. Flow %
-7.62%
Top 10 Hldgs %
60.81%
Holding
44
New
5
Increased
15
Reduced
15
Closed
9

Top Buys

1
PM icon
Philip Morris
PM
+$20.7M
2
BAC icon
Bank of America
BAC
+$8.15M
3
SHPG
Shire pic
SHPG
+$7.43M
4
APD icon
Air Products & Chemicals
APD
+$7.37M
5
BMY icon
Bristol-Myers Squibb
BMY
+$7.36M

Top Sells

1
AGN
Allergan plc
AGN
+$16.1M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$12.4M
3
QGENF
QIAGEN NV
QGENF
+$9.01M
4
VVV icon
Valvoline
VVV
+$8.88M
5
LYB icon
LyondellBasell Industries
LYB
+$8.65M

Sector Composition

1 Healthcare 31.36%
2 Materials 15.13%
3 Communication Services 13.1%
4 Financials 11.45%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNH
1
CNH Industrial
CNH
$13.2B
$27.2M 8.96%
3,854,920
+256,110
+7% +$1.79M
TIMB icon
2
TIM SA
TIMB
$10.6B
$20.5M 6.77%
1,741,172
+347,649
+25% +$4.35M
PM icon
3
Philip Morris
PM
$301B
$20.4M 6.73%
+223,323
New +$20.7M
APD icon
4
Air Products & Chemicals
APD
$65.8B
$18.8M 6.21%
131,039
+52,636
+67% +$7.37M
BAC icon
5
Bank of America
BAC
$430B
$18.3M 6.04%
829,776
+422,992
+104% +$8.15M
GILD icon
6
Gilead Sciences
GILD
$167B
$17.9M 5.9%
250,289
-7,470
-3% -$555K
SHPG
7
DELISTED
Shire pic
SHPG
$16.8M 5.52%
98,441
+41,906
+74% +$7.43M
BMY icon
8
Bristol-Myers Squibb
BMY
$124B
$16.1M 5.3%
275,229
+134,704
+96% +$7.36M
ASH icon
9
Ashland
ASH
$3.14B
$14.4M 4.74%
269,395
-15,694
-6% -$862K
CELG
10
DELISTED
Celgene Corp
CELG
$14.1M 4.65%
121,916
-46,082
-27% -$5.13M
CRTO icon
11
Criteo
CRTO
$1.13B
$13.9M 4.59%
338,969
+38,420
+13% +$1.5M
C icon
12
Citigroup
C
$217B
$12.3M 4.04%
206,212
+336
+0.2% +$18.1K
AXTA icon
13
Axalta
AXTA
$6.92B
$11.6M 3.82%
426,299
+39,851
+10% +$1.05M
MRK icon
14
Merck
MRK
$315B
$11.4M 3.75%
202,698
-112,444
-36% -$6.58M
GCP
15
DELISTED
GCP Applied Technologies Inc.
GCP
$9.11M 3%
340,623
+46,083
+16% +$1.25M
GRA
16
DELISTED
W.R. Grace & Co.
GRA
$8.93M 2.94%
132,060
+24,011
+22% +$1.64M
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.41M 2.77%
101,548
-28,990
-22% -$2.49M
QGENF
18
DELISTED
QIAGEN NV
QGENF
$7.51M 2.47%
286,810
-344,180
-55% -$9.01M
ZBH icon
19
Zimmer Biomet
ZBH
$17.6B
$6.19M 2.04%
+61,798
New +$6.62M
DBVT
20
DBV Technologies
DBVT
$870M
$4.35M 1.43%
12,369
-262
-2% -$94.1K
UBS icon
21
UBS Group
UBS
$173B
$4.19M 1.38%
250,000
-342,656
-58% -$5.16M
HAL icon
22
Halliburton
HAL
$29.4B
$3.23M 1.07%
59,797
-10,580
-15% -$527K
CHTR icon
23
Charter Communications
CHTR
$16.2B
$2.71M 0.89%
9,412
+3,518
+60% +$947K
APC
24
DELISTED
Anadarko Petroleum
APC
$2.3M 0.76%
32,995
-8,216
-20% -$534K
OXY icon
25
Occidental Petroleum
OXY
$54.6B
$2.15M 0.71%
30,181
+6,559
+28% +$466K
1
2

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Exane Asset Management held 44 positions worth $304M, down 4.8% from $319M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Exane Asset Management withdrew a net $23.2M in Q4 2016, closing 9 positions and reducing 15 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 39% a quarter earlier, followed by Materials and Communication Services.

Against the trend, Exane Asset Management opened a new position in Philip Morris worth $20.4M.

  • Exane Asset Management's largest Q4 2016 buy was Philip Morris: 223,323 shares worth $20.4M.
  • Exane Asset Management added most to Bank of America in Q4 2016, an estimated $8.15M increase.
  • Exane Asset Management's biggest Q4 2016 reduction was QIAGEN NV, cutting an estimated $9.01M.
  • Exane Asset Management fully exited Allergan plc in Q4 2016, selling an estimated $16.1M.
  • Exane Asset Management's ten largest holdings make up 61% of its $304M portfolio in Q4 2016.
  • Exane Asset Management opened 5 new positions and closed 9 in Q4 2016.
  • Exane Asset Management's portfolio value fell 4.8% quarter-over-quarter to $304M.

Based on Exane Asset Management's 13F filing for Q4 2016, filed 31 Jan 2017.